US 7,488,836 B2
Costunolide derivatives
Weiguo Su, Shanghai (China); Hong Jia, Shanghai (China); Weihan Zhang, Shanghai (China); Xiaoqiang Yan, Shanghai (China); Jifeng Duan, Shanghai (China); Tao Wang, Shanghai (China); and Yu Cai, Shanghai (China)
Assigned to Hutchison Medipharma Enterprises Limited, Nassau (Bahamas)
Filed on Aug. 14, 2007, as Appl. No. 11/838,503.
Claims priority of provisional application 60/837770, filed on Aug. 15, 2006.
Prior Publication US 2008/0051396 A1, Feb. 28, 2008
Int. Cl. C07D 307/00 (2006.01)
U.S. Cl. 549—302 12 Claims
 
1. A compound of Formula (I):

OG Complex Work Unit Drawing
wherein:
X is CH2 and Y is NR1R2, OCONR1R2; or X is C(O) and Y is NR1R2; in which R1 is alkyl, cycloalkyl, alkenyl, alkynyl, aryl, or heteroaryl; R2 is H, alkyl, cycloalkyl, heterocycloalkyl, alkenyl, alkynyl, aryl, or heteroaryl, or R1, R2, and N to which they are attached, taken together, form a saturated or unsaturated 3-8 membered ring, optionally substituted with R1′, OR2′, NR2′R3′, SR2′, C(O)R2′, CO2R2′, or C(O)NR2′R3′, R1′ being alkyl, cycloalkyl, heterocycloalkyl, alkenyl, alkynyl, aryl, or heteroaryl, and each of R2′ and R3′, independently, being H, alkyl, cycloalkyl, heterocycloalkyl, alkenyl, alkynyl, aryl, or heteroaryl; and
Z is a bond;
or a pharmaceutically acceptably salt thereof.